Cancer biomarkers for precision prevention and early detection.
We are a translational cancer research lab focused on developing clinically practical biomarker strategies to improve early detection, risk stratification, and precision prevention. Our work integrates discovery-to-translation pipelines across human cohorts and experimental models, with emphasis on reproducible assays and biologically grounded interpretation.
Affiliation: Cedars-Sinai Medical Center
We welcome motivated trainees and collaborators. See Opportunities or reach out via Contact.
© Furuya Lab. All rights reserved.